Stock Price
34.90
Daily Change
0.16 0.45%
Monthly
-15.49%
Yearly
-5.45%
Q2 Forecast
33.07

Qiagen NV reported $0.52 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.46 0.49 May/04
FY2025Q4 Dec/2025 0.50 0.52 0.59 Feb/04
FY2025Q3 Sep/2025 0.53 0.5 0.54 Nov/04
FY2025Q2 Jun/2025 0.60 0.53 0.51 Aug/05
FY2025Q1 Mar/2025 0.49 0.47 0.43 May/07




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
argenx SE USD 6.8 2.36 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025